계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Beijing Gene+ Technology
company
About
Beijing Gene+, also known as Beijing Gene Plus, provides gene testing services for cancer prevention
- 251 - 500
Highlights
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $30M
- Industries
- Health Care,Life Science,Medical
- Founded date
- Jan 1, 2015
- Number Of Employee
- 251 - 500
- Operating Status
- Active
Beijing Gene+, also known as Beijing Gene Plus, provides gene testing services for cancer prevention, early detection, as well as providing data for the implementation of precision medicine.The company claims to operate in around 100 hospitals and have served thousands of cancer patients in China.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$58M
Beijing Gene+ Technology has raised a total of
$58M
in funding over 2 rounds. Their latest funding was raised on
Sep 30, 2019 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 30, 2019 | Series B | $28M | 1 | — | — | Detail |
| Sep 14, 2016 | Series A | $30M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Beijing Gene+ Technology is funded by 2 investors.
Desun Investments
and Huoshanshi Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Desun Investments
|
— | Series B |
|
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
